StonvexLoading…
StonvexCore line items from AWK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $5.12B | $4.65B | $4.22B | $3.76B |
Operating Income | $1.88B | $1.72B | $1.50B | $1.27B |
Net Income | $1.11B | $1.05B | $944.00M | $820.00M |
EPS (Diluted) | $5.69 | $5.39 | $4.90 | $4.51 |
Total Assets | $35.44B | $32.83B | $30.30B | $27.79B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $98.00M | $96.00M | $330.00M | $85.00M |
Free Cash Flow OCF − CapEx | $-1.07B | $-811.00M | $-701.00M | $-1.19B |
Shares Outstanding | 195.00M | 195.00M | 193.00M | 182.00M |